Sumitomo Pharma Co., Ltd. (4506.T) JPX

Currency In JPY

Key Executives

Name	Title	Pay	Year Born
Toru Kimura	Representative Director, President & Chief Executive Officer	101M	1960
Koji Yamazaki	Exec. Off. of Sales & Mark. Div., SVP, Hd. of Sales & Mark. Div. Dep. Hd. of Japan Bus. Unit	0	N/A
Hideyuki Harada	Mng. Exe. Off. of Supply Chain Div., SVP, Hd. of Supply Chain Div. & Hd. of Japan Bus. Unit	0	N/A
Motoyuki Sakai	EVP of Global Corp. Strategy, Fin. Admin, Ex. Aff., CG, Corp. Comm.; IT Mgmt & DA & Rep. Director	0	1961
Kimihiro Mizuno	Executive Officer Legal & Compliance and Intellectual Property	0	N/A
Kenji Ueno	Executive Officer, Senior Vice President and Deputy Head of Research and Development Division (CMC)	0	N/A
Koichi Kozuki	E.O. of Corp. Reg. Comp., Bus Dev mgmt & Q.A., Sr. VP, Hd of C.R.C. & Q.A. Div & Dp. Hd of Jap. Bus.	0	N/A
Yumi Sato	Managing Exe. Officer of Research & Dev. Div. Senior Vice President and Head of Research & Development Division	0	N/A
Tsutomu Nakagawa	Managing Executive Officer & Director	0	1968
Megumi Maruyama	Vice President & Head of Corporate Communications	0	N/A
Katsuhiko Nishida	EO, SVP of S&M & Head of Japan BU Deputy	0	N/A
Isao Shimizu	Exec. Off.,SVP, Dep. Head of R&D Div. & Corp. Reg.Comp & Quality Assurace. Div.	0	N/A
Shunji Kobayashi	Executive Officer of Human Resources	0	N/A

Name

Title

Pay

Year Born

Toru Kimura

Representative Director, President & Chief Executive Officer

101M

1960

Koji Yamazaki

Exec. Off. of Sales & Mark. Div., SVP, Hd. of Sales & Mark. Div. Dep. Hd. of Japan Bus. Unit

N/A

Hideyuki Harada

Mng. Exe. Off. of Supply Chain Div., SVP, Hd. of Supply Chain Div. & Hd. of Japan Bus. Unit

N/A

Motoyuki Sakai

EVP of Global Corp. Strategy, Fin. Admin, Ex. Aff., CG, Corp. Comm.; IT Mgmt & DA & Rep. Director

1961

Kimihiro Mizuno

Executive Officer Legal & Compliance and Intellectual Property

N/A

Kenji Ueno

Executive Officer, Senior Vice President and Deputy Head of Research and Development Division (CMC)

N/A

Koichi Kozuki

E.O. of Corp. Reg. Comp., Bus Dev mgmt & Q.A., Sr. VP, Hd of C.R.C. & Q.A. Div & Dp. Hd of Jap. Bus.

N/A

Yumi Sato

Managing Exe. Officer of Research & Dev. Div. Senior Vice President and Head of Research & Development Division

N/A

Tsutomu Nakagawa

Managing Executive Officer & Director

1968

Megumi Maruyama

Vice President & Head of Corporate Communications

N/A

Katsuhiko Nishida

EO, SVP of S&M & Head of Japan BU Deputy

N/A

Isao Shimizu

Exec. Off.,SVP, Dep. Head of R&D Div. & Corp. Reg.Comp & Quality Assurace. Div.

N/A

Shunji Kobayashi

Executive Officer of Human Resources

N/A

Description

Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across Japan, North America, China, and other international territories. The company's pharmaceutical offerings address a broad spectrum of medical needs. These include treatments for conditions such as Parkinson's disease, depression, type 2 diabetes, systemic fungal infections, hypertension, pruritus, chronic obstructive pulmonary disease (COPD), angina pectoris, and arrhythmia. Additionally, they manufacture atypical antipsychotics, antiepileptics, carbapenem antibiotics, gastrointestinal products, and specialized medications for Anderson-Fabry disease. Beyond healthcare, Sumitomo Pharma provides food components and enhancement agents like polysaccharides, along with savory flavorings such as soups and bouillons. The company also supplies chemical raw materials, which encompass pharmaceutical excipients, components for personal care products, substances used in coatings and industrial applications, and electronic materials. Moreover, it produces veterinary therapeutic solutions designed for domestic pets, specifically dogs and cats, as well as for various farm animals, including cattle, swine, poultry, horses, and cultivated fish. To drive innovation, Sumitomo Pharma fosters partnerships with several organizations. These collaborators include Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. The company also maintains a joint development agreement with SanBio Company Limited, a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd., and a strategic alliance with Roivant Sciences Ltd. Originally established in 1897, the company, headquartered in Osaka, Japan, was known as Sumitomo Dainippon Pharma Co., Ltd. until it adopted its current name, Sumitomo Pharma Co., Ltd., in April 2022. It functions as a subsidiary of Sumitomo Chemical Company, Limited.